共 45 条
- [1] Younossi ZM(2016)Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes Hepatology 64 73-84
- [2] Yki-Järvinen H(2014)Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome Lancet Diabetes Endocrinol. 2 901-910
- [3] McPherson S(2015)Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management J. Hepatol. 62 1148-1155
- [4] Ascha MS(2010)The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis Hepatology 51 1972-1978
- [5] Toyokuni S(2016)Oxidative stress as an iceberg in carcinogenesis and cancer biology Arch. Biochem. Biophys. 595 46-49
- [6] Kato J(2001)Normalization of elevated hepatic 8-hydroxy-2-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet Cancer Res. 61 8697-8702
- [7] Tanaka S(2013)Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma J. Gastroenterol. 48 1249-1258
- [8] Bugianesi E(2007)Non-alcoholic steatohepatitis and cancer Clin. Liver Dis. 11 191-207
- [9] Hoki T(2015)Increased duodenal iron absorption through up-regulation of divalent metal transporter 1 from enhancement of iron regulatory protein 1 activity in patients with nonalcoholic steatohepatitis Hepatology 62 751-761
- [10] Nakashima T(2005)Elevation of serum thioredoxin levels in patients with nonalcoholic steatohepatitis Hepatol. Res. 33 135-137